Work

The CXCR4 Antagonist, BL8040, Is Highly Active Against Human T-ALL in Preclinical Models

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-117213

Authors: Jun Xia, Matthew RM Jotte, Stephanie Sun, Geoffrey L. Uy, Abi Vainstein, Ella Sorani, Osnat Bohana-Kashtan, Stephen Shaw, Daniel C. Link

Institutions: Washington University in St. Louis, University of Chicago, BioLineRx Ltd. (Israel)

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2913880756

Cites:

Cited by: 3

Related to: 10